ARCHIVES

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

Also Von Eschenbach’s NCI Farewell Reception, Gift Solicitation, Raises Legal And Ethical Issues.

May 5, 2006

Letter; ASSIST Prevents Cancer, Should Remain in NCI Portfolio

July 4, 1997

NCAB Hears Good News: FY 92 Budget Allows NCI To Increase Levels Of Most Programs

November 29, 1991

Radiation Dose Reconstruction Methods For Compensation Cases In Final Rule By HHS.

May 17, 2002

Arizona Cancer Center Wins Core Grant Renewal

June 26, 2009

Possible Association Between Agent Orange, AML, IOM Says.

April 27, 2001